We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.38%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$16.4B
AUM Growth
+$994M
(+6.5%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-16.31%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
653
New
51
Increased
212
Reduced
120
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$65.8M |
| 2 |
Cboe Global Markets
CBOE
|
+$65.4M |
| 3 |
Elevance Health
ELV
|
+$49.3M |
| 4 |
Mohawk Industries
MHK
|
+$49.2M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$44.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANTX
Anthem, Inc.
ANTX
|
+$77.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$69.6M |
| 3 |
AbbVie
ABBV
|
+$35.3M |
| 4 |
FRC
First Republic Bank
FRC
|
+$31.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.47% |
| 2 | Technology | 8.96% |
| 3 | Healthcare | 8.59% |
| 4 | Communication Services | 6.53% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CALL
Expedia Group
EXPE
$31.2B
| $4.29M | 0.03% |
+35,700
| New | +$4.12M |
|
327
Idexx Laboratories
IDXX
$42.9B
| $4.29M | 0.03% |
19,668
-4,579
| -19% | -$944K |
|
328
TE Connectivity
TEL
$58.8B
| $4.25M | 0.03% |
47,229
-13,748
| -23% | -$1.32M |
|
|
AIV
329
Aimco
AIV
$380M
| $4.24M | 0.03% |
751,551
+138,726
| +23% | +$754K |
|
330
Vale
VALE
$62.9B
| $4.23M | 0.03% |
330,056
-63,230
| -16% | -$863K |
|
331
Johnson Controls International
JCI
$87.5B
| $4.22M | 0.03% |
126,027
+15,097
| +14% | +$524K |
|
332
Consolidated Edison
ED
$41.6B
| $4.21M | 0.03% |
53,995
+10,076
| +23% | +$770K |
|
333
Public Storage
PSA
$60.2B
| $4.2M | 0.03% |
18,532
+2,223
| +14% | +$463K |
|
334
Equinix
EQIX
$107B
| $4.16M | 0.03% |
9,667
+1,157
| +14% | +$468K |
|
335
Avery Dennison
AVY
$12.3B
| $4.14M | 0.03% |
40,597
+4,088
| +11% | +$432K |
|
336
Devon Energy
DVN
$51.9B
| $4.1M | 0.03% |
93,166
-28,902
| -24% | -$1.12M |
|
337
DXC Technology
DXC
$1.63B
| $4.06M | 0.02% |
50,399
-2,668
| -5% | -$229K |
|
338
Pentair
PNR
$10.2B
| $4M | 0.02% |
94,933
-29,488
| -24% | -$1.33M |
|
339
F5
FFIV
$22.1B
| $3.99M | 0.02% |
23,153
-1,079
| -4% | -$180K |
|
340
Aflac
AFL
$63.9B
| $3.96M | 0.02% |
92,065
+10,992
| +14% | +$494K |
|
341
Dollar General
DG
$25.9B
| $3.95M | 0.02% |
40,071
-6,161
| -13% | -$593K |
|
342
Edison International
EIX
$30.7B
| $3.94M | 0.02% |
62,345
+7,468
| +14% | +$466K |
|
|
GRMN
343
Garmin
GRMN
$46.9B
| $3.92M | 0.02% |
64,222
+7,687
| +14% | +$462K |
|
|
BLD
344
DELISTED
TopBuild
BLD
| $3.92M | 0.02% |
49,999
| – | – |
|
345
Williams Companies
WMB
$90.5B
| $3.92M | 0.02% |
144,395
+46,931
| +48% | +$1.24M |
|
|
CERN
346
DELISTED
Cerner Corp
CERN
| $3.91M | 0.02% |
65,441
+7,837
| +14% | +$464K |
|
347
Cigna
CI
$76.6B
| $3.89M | 0.02% |
22,913
-21,961
| -49% | -$3.8M |
|
|
ORIG
348
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $3.85M | 0.02% |
130,654
| – | – |
|
349
Hartford Financial Services
HIG
$38.5B
| $3.84M | 0.02% |
75,130
+6,722
| +10% | +$352K |
|
350
Zimmer Biomet
ZBH
$17.7B
| $3.83M | 0.02% |
35,384
+4,240
| +14% | +$461K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Calamos Advisors held 653 positions worth $16.4B, up 6.5% from $15.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $2.67B in Q2 2018, closing 58 positions and reducing 120 holdings. Its most notable exit was Anthem, Inc., an estimated $77.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Cboe Global Markets worth $64.5M.
- Calamos Advisors's largest Q2 2018 buy was Cboe Global Markets: 619,398 shares worth $64.5M.
- Calamos Advisors added most to Goldman Sachs in Q2 2018, an estimated $65.8M increase.
- Calamos Advisors's biggest Q2 2018 reduction was Allergan plc, cutting an estimated $69.6M.
- Calamos Advisors fully exited Anthem, Inc. in Q2 2018, selling an estimated $77.5M.
- Calamos Advisors's ten largest holdings make up 20% of its $16.4B portfolio in Q2 2018.
- Calamos Advisors opened 51 new positions and closed 58 in Q2 2018.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $16.4B.
Based on Calamos Advisors's 13F filing for Q2 2018, filed 17 Jul 2018.